Aortic valve repair or replacement

From WikiAnesthesia
Revision as of 08:15, 17 February 2026 by Zining Chen (talk | contribs) (Patient evaluation table)
Aortic valve repair or replacement
Anesthesia type

General

Airway

ETT

Lines and access

PIV, Arterial line, Central line, +/- PA catheter

Monitors

Standard ASA, arterial line BP, CVP +/- PAP, TEE, NIRS

Primary anesthetic considerations
Preoperative

-Severity of lesion (AS vs AR) -Symptoms (syncope, angina, dyspnea) -LV function and size (hypertrophy) -Coronary disease (concomitant CABG) -Pulmonary HTN -Rhythm (atrial fibrillation)

Intraoperative

-Hemodynamic goals (AS vs AR) -Full heparinization before CPB -Myocardial protection and de-airing -Conduction disturbance after valve replacement -Weaning from CPB: LV/RV function, valve seating, gradients

Postoperative

-Vasoplegia -Low cardiac output syndrome -Conduction abnormalities -Bleeding -Early vs delayed extubation

Article quality
Editor rating
Unrated
User likes
0

Aortic valve repair or replacement is performed for aortic stenosis (AS), aortic regurgitation (AR), or mixed disease. It is performed with sternotomy under cardiopulmonary bypass (CPB). Surgical aortic valve replacement (SAVR) involves excision of the native valve and implantation of a mechanical or bioprosthetic prosthesis.

Indications:

  • Symptomatic severe AS
  • Severe AR with LV dilation or dysfunction
  • Endocarditis with structural destruction
  • Concomitant CABG requirement
  • Root/ascending aortic pathology

Unlike Transcatheter aortic valve replacement, SAVR allows:

  • Complete annular debridement
  • Abscess repair
  • Annular enlargement
  • Root replacement
  • Concomitant multivessel CABG
  • Durability advantage in younger patients

Transcatheter aortic valve replacement (TAVR) is preferred in:

  • Elderly patients
  • High or prohibitive surgical risk
  • Frailty or hostile chest[1]

Preoperative management

Patient evaluation

System Considerations
Neurologic -Syncope history (critical AS)

-Carotid disease (stroke risk)

Cardiovascular -AVA, mean gradient, velocity (severity)

-LVEF, LVH vs LV dilation (pressure or volume overload)

-Diastolic dysfunction (preload sensitivity)

-pulmonary HTN (RV risk post bypass)

-CAD (concomitant CABG)

-Rhythm (atrial fibrillation)

Pulmonary -Restrictive lung physiology (HF/sternotomy)

-COPD (prolonged vent weaning)

Gastrointestinal -Dysphagia, esophageal/GI tract surgeries (TEE)
Hematologic -Anticoagulation use, blood products available
Renal -Baseline Cr, kidney disease (CPB AKI risk)
Endocrine -DM
Other -Endocarditis (longer CPB)

Labs and studies

Operating room setup

Patient preparation and premedication

Regional and neuraxial techniques

Intraoperative management

Monitoring and access

Induction and airway management

Positioning

Maintenance and surgical considerations

Emergence

Postoperative management

Disposition

Pain management

Potential complications

Procedure variants

Variant 1 Variant 2
Unique considerations
Position
Surgical time
EBL
Postoperative disposition
Pain management
Potential complications

References

  1. Otto, Catherine M.; Nishimura, Rick A.; Bonow, Robert O.; Carabello, Blase A.; Erwin, John P.; Gentile, Federico; Jneid, Hani; Krieger, Eric V.; Mack, Michael; McLeod, Christopher; O’Gara, Patrick T. (2021-02-02). "2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". Circulation. 143 (5). doi:10.1161/CIR.0000000000000923. ISSN 0009-7322.